Literature DB >> 8754845

Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases.

K M Latham1, S W Eastman, A Wong, P W Hinds.   

Abstract

Rat fibroblasts transformed by a temperature-sensitive mutant of murine p53 undergo a reversible growth arrest in G1 at 32.5 degrees C, the temperature at which p53 adopts a wild-type conformation. The arrested cells contain inactive cyclin-dependent kinase 2 (cdk2) despite the presence of high levels of cyclin E and cdk-activating kinase activity. This is due in part to p53-dependent expression of the p2l cdk inhibitor. Upon shift to 39 degrees C, wild-type p53 is lost and cdk2 activation and pRb phosphorylation occur concomitantly with loss of p2l. This p53-mediated growth arrest can be abrogated by overexpression of cdk4 and cdk6 but not cdk2 or cyclins, leading to continuous proliferation of transfected cells in the presence of wild-type p53 and p2l. Kinase-inactive counterparts of cdk4 and cdk6 also rescue these cells from growth arrest, implicating a noncatalytic role for cdk4 and cdk6 in this resistance to p53-mediated growth arrest. Aberrant expression of these cell cycle kinases may thus result in an oncogenic interference with inhibitors of cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754845      PMCID: PMC231443          DOI: 10.1128/MCB.16.8.4445

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  95 in total

1.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

2.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

Authors:  S W Lowe; H E Ruley; T Jacks; D E Housman
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

3.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

4.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Authors:  Z A Khatib; H Matsushime; M Valentine; D N Shapiro; C J Sherr; A T Look
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

5.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.

Authors:  D Spitkovsky; P Steiner; R V Gopalkrishnan; M Eilers; P Jansen-Dürr
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

7.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

8.  Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest.

Authors:  H J Lin; V Eviner; G C Prendergast; E White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.

Authors:  L Zhu; E Harlow; B D Dynlacht
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

10.  The cdk2 kinase is required for the G1-to-S transition in mammalian cells.

Authors:  L H Tsai; E Lees; B Faha; E Harlow; K Riabowol
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  11 in total

1.  Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle.

Authors:  L Latella; A Sacco; D Pajalunga; M Tiainen; D Macera; M D'Angelo; A Felici; A Sacchi; M Crescenzi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension.

Authors:  S Huang; C S Chen; D E Ingber
Journal:  Mol Biol Cell       Date:  1998-11       Impact factor: 4.138

3.  Perturbation of the p53 response by human papillomavirus type 16 E7.

Authors:  E S Hickman; S Bates; K H Vousden
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein.

Authors:  F Tiemann; P W Hinds
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.

Authors:  M D Planas-Silva; R A Weinberg
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription.

Authors:  P Fojas de Borja; N K Collins; P Du; J Azizkhan-Clifford; M Mudryj
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

8.  Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation.

Authors:  Y Liu; S A Bohn; J L Sherley
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

9.  Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.

Authors:  K Alexander; P W Hinds
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

10.  Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.

Authors:  H Jiang; H S Chou; L Zhu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.